Shimon Slavin, MD, the CTCI Medical and Scientific Director, is
internationally renowned for his innovative use of cell therapy and
immunotherapy in treating cancer and life-threatening non-malignant
His pioneering work in cell therapy of cancer by donor
lymphocyte infusions (DLI), post allogeneic stem cell transplantation,
and nonmyeloablative stem cell transplantation (NST) is now in worldwide
use. NST is much safer, less difficult for the patient, and more
economical than previously developed procedures.
has also developed personalized approaches to treat cancer using
immunotherapy mediated by innovative targeted cell therapy and vaccines;
to immune-regulate autoimmune diseases; and to induce transplantation
tolerance to bone marrow and organ allografts. Prof. Slavin pioneered
the use of multi-potent stem cells for regenerative medicine, focusing
on down-regulation of harmful self-reactive lymphocytes and repair of
damaged tissues and organs.
Prof. Slavin conducts basic clinical
research and clinical trials of novel methods to make a patient's
immune system effective in targeting and combating the patient's
disease. The world's leading peer-reviewed journals have published over 500 articles
of his research. He has authored 4 books on his medical research and innovations.
Slavin earned his MD from the Hadassah Hebrew University School of
Medicine in Jerusalem, Israel. He trained in immunology and rheumatology
at Stanford University in California and at the Fred Hutchinson Bone
Marrow Transplantation Center in Seattle, Washington.
Harry Brenner brings over 40 years of experience in oncology and
radiation therapy to the International Center for Cell Therapy &
Cancer Immunotherapy. Prof. Brenner was the Director of Radiation
Oncology at the Rabin Medical Center and the Medical Director for Machon
Eshkol Community Medical Service in Israel. He has also served as the
Director of the Institute of Radiotherapy and Oncology at Sheba Medical
Center, Chairman of the Israel National Examination Board for Oncology,
and Chairman of Oncology at Tel Aviv University. Prof. Brenner has
served as a consulting oncologist for several of the leading hospitals
Prof. Brenner has held numerous visiting positions in
the most prestigious international medical institutions, such as
Memorial Sloan-Kettering Cancer Center, Brown University, Mount Sinai
Medical Center, Cornell University Medical Center, Royal College of
Radiologists, and The Royal Marsden Hospital.
career, Prof. Brenner has been granted prestigious awards for excellence
in medicine. He has published over 60 articles in leading international
peer-reviewed journals on a variety of topics. Prof. Brenner earned his
medical degrees from the University of Cape Town, South Africa.